Regional Insurer To Cover Prescription Digital Therapeutics, Says Model Is Replicable

Pittsburgh-based Highmark Health tells Inside TeleHealth it hopes its new policy to cover prescription digital therapeutics (PDTs) will pave the way for insurers to offer the interventions more broadly.

Tags: 
Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 11/25/2022
FDA Volume: 
Vol. 28, No. 47
Author: 

Regional Insurer To Cover Prescription Digital Therapeutics, Says Model Is Replicable

Pittsburgh-based Highmark Health tells Inside TeleHealth it hopes its new policy to cover prescription digital therapeutics (PDTs) will pave the way for insurers to offer the interventions more broadly.

Site Name: 
InsideHealthPolicy.com
Author: 


WTO Members Discuss Expansion Of TRIPS Waiver

While the United States takes a bit of a Thanksgiving breather this week, trade officials in Geneva and Brussels have a full plate of issues to deal with as the World Trade Organization tries to figure out whether to move forward with an intellectual property waiver for COVID-19 diagnostics and therapeutics while EU officials discuss Europe’s trade ties with the United States, as well as the bloc’s increasingly complicated relationship with China.

Tags: 
Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 11/25/2022
FDA Volume: 
Vol. 28, No. 47
Author: 

Fowler: Mandatory Demonstrations May Return Post-COVID-19

CMS innovation center chief Liz Fowler said the agency could consider mandatory demonstrations after the health sector has recovered from the COVID-19 pandemic, but this isn’t the time for the center to move on such demos.

Site Name: 
InsideHealthPolicy.com
CMS Issue: 
Inside CMS - 11/24/2022
CMS Volume: 
Vol. 25, No. 47
Author: 

Former FDAer: COVID Shows Fast Authorizations Work, But Better Surveillance Needed

Health care can benefit from the streamlined FDA authorization processes used during the pandemic, former FDA Principal Deputy Commissioner Amy Abernethy said, but the agency needs to do a better job collecting postmarket data and communicating with the public.

Tags: 
Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 11/25/2022
FDA Volume: 
Vol. 28, No. 47
Author: 








Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.